Wedbush analyst Daniel Ives maintained a Buy rating on Elastic (ESTC – Research Report) today and set a price target of $135.00. The company’s ...

Wedbush analyst David Nierengarten maintained a Buy rating on AnaptysBio (ANAB – Research Report) today and set a price target of $40.00. The ...

Palantir is undoubtedly near the top of many investors' watchlists. But Wall Street estimates the company's adjusted earnings will increase 35% in 2025. That consensus makes the current valuation of ...

Recently, Dan Ives of Wedbush Securities suggested that Palantir Technologies ( PLTR -4.63%) could become a trillion-dollar company within the next few years. Should that happen, Palantir would be the ...

TikTok has returned to Apple and Google app stores nearly a month after a new security law forced its removal, AFP journalists confirmed on Thursday. The Chinese-owned social media platform faces ...

In a note to investors, Dan Ives, senior equity analyst for Wedbush Securities, called the company's China strategy the "biggest missing piece in Apple's AI launch," noting that it's been in a ...

The app’s availability in the U.S. has been thrown into jeopardy over data privacy and national security concerns.

Welltower (NYSE:WELL) was upgraded at Wedbush after the senior housing REIT "impressed with the growth outlook for 2025". The healthcare REIT turned in Q4 earnings and revenue that topped Wall ...

The future of TikTok remains uncertain, but with the app still active—and now back on the App Store—following its January 19 ban deadline, it seems to be doing better than expected.

Chinese startup DeepSeek has debuted an AI app that challenges OpenAI's ChatGPT and other U.S. rivals, sending a shock through Wall Street.

Kura Oncology, Inc. (NASDAQ:KURA – Free Report) – Stock analysts at Wedbush issued their FY2029 ... also recently issued reports on KURA. JMP Securities reissued a “market outperform ...